drugset / Trial / NCT02182960

Bioavailability of Ibuprofen Enantiomers Compared With Standard Brufen Sirup in Healthy Male Volunteers

NCT02182960

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Pharmacokinetics (relative bioavailability), safety and tolerability

Timeline

Start
1998-09
Primary completion
1998-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule

Indications

No indication recorded.